Drug-induced immune hemolytic anemia (DIIHA) occurs rarely. To date, about 100 drugs
have been implicated in causing DIIHA and/or a positive direct antiglobulin test (DAT). The …

Drug‐induced immune haemolytic anaemia is a rare but serious condition. This study
investigated the possibility of drug aetiology of immune haemolytic anaemia (IHA) in 134 …

Background: Drug-induced immune haemolytic anaemia (DIHA) is difficult to diagnose, and
its true incidence remains obscure. Here, we present cases of DIHA identified at our institute …

Because of their broad-spectrum bactericidal activity, amoxicillin (AMX) and third-generation
cephalosporins (TGC) are widely used for the prophylaxis and treatment of established …

Background and objectives: In this report, we will describe the occurrence of intravascular
immune haemolytic anaemia (IHA) associated with ceftriaxone and/or its metabolites in two …

BACKGROUND: Ceftriaxone, a third‐generation cephalosporin, is commonly used to
prevent and treat infections. Since 1987, it has been the second most common cause of drug …

BACKGROUND: Ceftriaxone, a third‐generation cephalosporin, has been reported to
occasionally cause fatal drug‐induced immune hemolytic anemia (DIHA). A clinical and …

Objectives: To describe a case of a ceftriaxone-induced hemolytic anemia and hepatitis
leading to multiple organ failure and death in an adolescent with hemoglobin SC disease …

Over the last decade, second and third generation cephalosporins have been the most
common drugs causing hemolytic anemia (HA). Of these cases, 20% have been attributed to …

头孢曲松为临床广泛应用的第三代头孢菌素类抗生素, 其常见不良反应有过敏反应和胃肠道反应
. 头孢曲松还可引起溶血性贫血, 近年报道日益增多. 本文从国内外文献检索到头孢曲松引起的 …